Has the treatment gap for opioid use disorder narrowed in the U.S.?: A yearly assessment from 2010 to 2019"
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Has the treatment gap for opioid use disorder narrowed in the U.S.?: A yearly assessment from 2010 to 2019"
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF DRUG POLICY
Volume -, Issue -, Pages 103786
Publisher
Elsevier BV
Online
2022-08-04
DOI
10.1016/j.drugpo.2022.103786
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Heroin Use Cannot Be Measured Adequately with a General Population Survey
- (2021) Peter Reuter et al. ADDICTION
- It will end in tiers: A strategy to include “dabblers” in the buprenorphine workforce after the X-waiver
- (2021) Brendan Saloner et al. Substance Abuse
- Characteristics and correlates of U.S. clinicians prescribing buprenorphine for opioid use disorder treatment using expanded authorities during the COVID-19 pandemic
- (2021) Christopher M. Jones et al. DRUG AND ALCOHOL DEPENDENCE
- Association of Opioid Agonist Treatment With All-Cause Mortality and Specific Causes of Death Among People With Opioid Dependence
- (2021) Thomas Santo et al. JAMA Psychiatry
- Potential barriers to filling buprenorphine and naltrexone prescriptions among a retrospective cohort of individuals with opioid use disorder
- (2021) Jake R. Morgan et al. JOURNAL OF SUBSTANCE ABUSE TREATMENT
- Low-threshold Buprenorphine Treatment in a Syringe Services Program
- (2021) Andrea Jakubowski et al. Journal of Addiction Medicine
- Trends in and Characteristics of Drug Overdose Deaths Involving Illicitly Manufactured Fentanyls — United States, 2019–2020
- (2021) Julie O’Donnell et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Availability of Medications for the Treatment of Alcohol and Opioid Use Disorder in the USA
- (2020) Amanda J. Abraham et al. Neurotherapeutics
- Low Barrier Tele-Buprenorphine in the Time of COVID-19
- (2020) Miriam Harris et al. Journal of Addiction Medicine
- Increases in Providers With Buprenorphine Waivers in the United States From 2016 to 2019
- (2020) Robin Ghertner et al. PSYCHIATRIC SERVICES
- Monthly Patient Volumes of Buprenorphine-Waivered Clinicians in the US
- (2020) Alexandra Duncan et al. JAMA Network Open
- A Critical Review of the Social and Behavioral Contributions to the Overdose Epidemic
- (2020) Magdalena Cerdá et al. Annual Review of Public Health
- Disparities Between US Opioid Overdose Deaths and Treatment Capacity
- (2019) James R. Langabeer et al. Journal of Addiction Medicine
- Medications for opioid use disorders: clinical and pharmacological considerations
- (2019) Nora D. Volkow et al. JOURNAL OF CLINICAL INVESTIGATION
- Are Policy Strategies for Addressing the Opioid Epidemic Partisan? A View from the States
- (2019) Colleen M. Grogan et al. JOURNAL OF HEALTH POLITICS POLICY AND LAW
- Estimated Prevalence of Opioid Use Disorder in Massachusetts, 2011–2015: A Capture–Recapture Analysis
- (2018) Joshua A. Barocas et al. AMERICAN JOURNAL OF PUBLIC HEALTH
- Vermont Hub-and-Spoke Model of Care for Opioid Use Disorder
- (2017) John R. Brooklyn et al. Journal of Addiction Medicine
- National and State Treatment Need and Capacity for Opioid Agonist Medication-Assisted Treatment
- (2015) Christopher M. Jones et al. AMERICAN JOURNAL OF PUBLIC HEALTH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now